Diabetic Retinopathy

Facing Diabetic Retinopathy: Protecting Vision When Diabetes Affects the Eyes

Diabetic retinopathy can be frightening because it often develops quietly. Many people feel well, see well, and continue daily life without realizing that diabetes is affecting the small blood vessels in the retina—the light-sensitive tissue at the back of the eye. For others, the first warning may be blurred vision, floaters, difficulty reading, or sudden changes in sight. Understandably, this can raise urgent questions: Will my vision recover? Do I need injections or laser treatment? Is surgery necessary? How quickly should I act?

The most important message is that diabetic retinopathy is treatable, especially when detected and managed early. Modern retinal care can slow progression, reduce swelling, treat abnormal blood vessels, and help preserve useful vision. Even in more advanced cases, specialist treatment may prevent further damage and, in selected situations, improve vision that has been affected by bleeding, retinal swelling, or traction on the retina.

Treatment is not only about the eye. Diabetic retinopathy is closely linked to overall diabetes control, blood pressure, kidney health, cholesterol levels, pregnancy, and the length of time a person has had diabetes. This is why effective care often requires coordination between retina specialists, endocrinologists, internal medicine physicians, cardiologists, nephrologists, and, when needed, other specialists. For international patients, this coordination is especially important: a clear diagnosis, a practical treatment plan, and organized follow-up can make care abroad safer and easier to navigate.

At Acibadem, diabetic retinopathy care is planned around detailed eye imaging, retinal specialist evaluation, evidence-based treatment options, and the patient’s wider medical picture. The aim is to protect sight while helping patients understand what is happening, why treatment is recommended, and what to expect during recovery and follow-up.

What Diabetic Retinopathy Treatment Is

Diabetic retinopathy treatment refers to a group of medical, laser, and surgical approaches used to manage diabetes-related damage to the retina. The retina depends on a healthy network of tiny blood vessels. Over time, high blood sugar can weaken these vessels, causing leakage, swelling, bleeding, and poor oxygen supply. In response, the eye may grow fragile new blood vessels that can bleed or pull on the retina. These changes may threaten central vision, peripheral vision, or both.

The type of treatment depends on the stage and pattern of disease. Some patients need close monitoring and better diabetes control rather than immediate eye procedures. Others need intravitreal injections—medication placed into the eye—to reduce retinal swelling or control abnormal blood vessel growth. Laser treatment may be used to seal leaking areas, reduce oxygen demand in the retina, or lower the risk of major bleeding in proliferative disease. In advanced cases, vitrectomy surgery may be recommended to remove blood, scar tissue, or traction that is affecting the retina.

Diabetic retinopathy care usually includes:

• Comprehensive retinal examination: A detailed eye exam after dilating the pupils to evaluate the retina, optic nerve, macula, and blood vessels.
• Retinal imaging: High-resolution scans and photographs to detect swelling, bleeding, vessel abnormalities, and areas of reduced circulation.
• Systemic medical review: Assessment of blood sugar control, blood pressure, kidney function, cholesterol, and other health factors that influence progression.
• Medication injections: Intravitreal anti-VEGF or steroid therapy in selected patients, especially for diabetic macular edema or abnormal new vessels.
• Laser therapy: Targeted retinal laser treatment for leaking vessels or broader retinal laser treatment for proliferative disease.
• Vitrectomy surgery: Microsurgical treatment for vitreous hemorrhage, tractional retinal detachment, dense scar tissue, or complications that cannot be managed with injections or laser alone.

There is no single treatment plan that fits every patient. A person with mild diabetic retinopathy and stable vision may need monitoring and metabolic optimization. A patient with swelling in the macula—the central part of the retina responsible for reading and recognizing faces—may need a course of injections. Someone with advanced proliferative disease may need urgent laser, injections, surgery, or a combination of these. The goal is to choose the safest and most effective pathway based on the individual eye, the fellow eye, the patient’s diabetes status, and the practical realities of follow-up.

Who May Need Diabetic Retinopathy Care

Anyone with diabetes can develop diabetic retinopathy. This includes people with type 1 diabetes, type 2 diabetes, gestational diabetes, and those who have had periods of undiagnosed or poorly controlled diabetes. The risk generally increases with the duration of diabetes and with long-term blood sugar, blood pressure, and lipid control. However, retinopathy can also occur in patients who feel physically well or who do not have obvious eye symptoms.

Many patients are referred for diabetic retinopathy care after a routine eye screening. Others seek care because they notice vision changes. Symptoms can vary depending on whether the macula is swollen, whether bleeding has occurred inside the eye, or whether the retina has developed traction or detachment.

Common symptoms and warning signs include:

• Blurred or fluctuating vision
• Difficulty reading, driving, or recognizing faces
• Dark spots, floaters, or cobweb-like shadows
• Distorted central vision
• Reduced night vision or contrast sensitivity
• Sudden loss of vision, which may occur with bleeding inside the eye
• Vision that improves and worsens with changes in blood sugar

Diagnosis begins with a careful medical and eye history. The retina specialist will ask about the type and duration of diabetes, recent blood sugar measurements, medications, blood pressure, kidney disease, pregnancy status, prior eye treatments, and any previous retinal surgery. The eye examination typically includes visual acuity testing, eye pressure measurement, pupil dilation, slit-lamp examination, and retinal evaluation.

Modern diagnostic pathways often include several forms of imaging. Optical coherence tomography provides cross-sectional images of the retina and is particularly useful for detecting diabetic macular edema. Retinal photography documents the severity and distribution of hemorrhages, exudates, and abnormal vessels. Fluorescein angiography may be used when the physician needs to understand retinal circulation, leakage, and areas that are not receiving enough blood flow. Wide-field imaging can help assess changes in the peripheral retina that may not be obvious during standard examination.

Patients may need specialized diabetic retinopathy care if they have been told they have moderate or severe nonproliferative diabetic retinopathy, proliferative diabetic retinopathy, diabetic macular edema, recurrent eye bleeding, retinal traction, or a high-risk retina before planned eye surgery such as cataract removal. International patients may also seek a second opinion when they have been advised to undergo repeated injections, laser therapy, or vitrectomy and want to understand the reasoning, expected benefits, risks, and alternatives.

Conditions and Indications Treated

Diabetic retinopathy is not one single pattern of disease. It exists on a spectrum, and treatment is selected according to the location and severity of retinal damage. A careful diagnosis helps determine whether monitoring, medical treatment, laser treatment, surgery, or combined therapy is most appropriate.

The main conditions and indications include:

• Nonproliferative diabetic retinopathy: Early to advanced retinal blood vessel damage without abnormal new vessel growth. Mild cases may be monitored, while more severe cases require close follow-up and sometimes treatment to reduce the risk of progression.
• Diabetic macular edema: Swelling in the macula caused by leaking retinal blood vessels. This is a common cause of reduced central vision and is often treated with intravitreal medication, sometimes combined with laser in selected cases.
• Proliferative diabetic retinopathy: Advanced disease in which fragile new blood vessels grow on the retina or optic nerve. These vessels can bleed and create scar tissue. Treatment may include laser, injections, and, in some cases, surgery.
• Vitreous hemorrhage: Bleeding into the gel-like cavity of the eye, often causing sudden floaters, haze, or marked vision loss. Some hemorrhages clear with observation, while persistent or recurrent bleeding may require vitrectomy.
• Tractional retinal detachment: Scar tissue pulls the retina out of position. This is a serious complication that may require retinal surgery, particularly when the macula is threatened or involved.
• Combined diabetic eye disease: Many patients have more than one issue, such as cataract, glaucoma, macular edema, and retinopathy. Treatment planning considers the entire eye, not only the retina.

The best timing of treatment depends on the patient’s vision, imaging results, severity in each eye, previous treatment response, general health, and ability to return for follow-up. In diabetic retinopathy, waiting until vision is severely affected may limit the chance of visual recovery. Early evaluation gives the retina specialist more options.

How Diabetic Retinopathy Treatment Is Performed

Initial Assessment and Preparation

The treatment process begins with a detailed retinal consultation. For international patients, bringing previous eye reports, retinal scans, angiography images, injection records, laser reports, operative notes, medication lists, and recent diabetes-related blood tests can be very helpful. If these are not available, the diagnostic evaluation can be repeated.

Before any procedure, the retina specialist reviews the diagnosis and explains whether the main problem is leakage, swelling, poor circulation, abnormal vessels, bleeding, scar tissue, or retinal traction. This distinction matters because each problem is treated differently. The physician also evaluates the fellow eye, because diabetic retinopathy often affects both eyes, though not always equally.

Preparation may include checking blood pressure and blood sugar, reviewing blood-thinning medications, assessing infection risk, and coordinating with an endocrinologist or internal medicine physician if diabetes control is unstable. Good systemic control is not a substitute for retinal treatment when eye disease is active, but it supports better long-term stability and reduces the risk of further damage.

Retinal Imaging and Treatment Planning

High-quality imaging guides the treatment plan. Optical coherence tomography helps identify fluid in or under the retina and measures macular thickness. Retinal photographs help monitor progression over time. Angiography may show leaking microaneurysms, abnormal new vessels, or areas of poor perfusion. In some cases, ultrasound is used when blood or cataract prevents a clear view of the retina.

These technologies help physicians make more precise decisions. For example, if vision loss is mainly due to diabetic macular edema, injections may be recommended. If there are widespread areas of oxygen-deprived retina and abnormal new vessels, laser therapy may be needed. If blood obscures the retina or scar tissue is pulling on the macula, surgery may be considered.

Intravitreal Injections

Intravitreal injections are among the most common treatments for diabetic macular edema and some cases of proliferative diabetic retinopathy. The medication is injected into the vitreous cavity, the gel-filled space inside the eye. The most commonly used drug category is anti-VEGF therapy, which targets a signal that contributes to leakage and abnormal blood vessel growth. Steroid-based medications may be considered in selected patients, particularly when inflammation contributes to swelling or when the response to other treatment is limited.

The injection itself is usually brief. The eye is cleaned carefully, anesthetic drops are used to numb the surface, and the medication is placed through the white part of the eye using a very fine needle. Patients may feel pressure but should not feel sharp pain. After the injection, the physician may check the eye and provide instructions about symptoms that require urgent attention, such as increasing pain, marked redness, or sudden vision worsening.

Injections are often given as a series rather than a single treatment. The schedule is individualized according to retinal swelling, vision, disease activity, and response. Some patients require more frequent treatment at the beginning, followed by longer intervals if the retina stabilizes. The need for repeated visits is an important part of planning for international patients, and the care team can help coordinate follow-up either at Acibadem or with the patient’s physician at home.

Laser Therapy

Laser treatment uses focused light energy to treat specific areas of the retina. In focal or grid laser therapy, selected leaking areas may be treated to reduce fluid accumulation in the macula. In panretinal photocoagulation, laser spots are placed in the peripheral retina to reduce the drive for abnormal new blood vessels in proliferative diabetic retinopathy.

Laser therapy is usually performed in an outpatient setting with anesthetic eye drops. A special contact lens may be placed on the eye to help focus the laser and stabilize the view. Patients may see flashes of light and may feel mild discomfort or pressure. The session length varies depending on the extent of treatment needed. Some patients require more than one session.

Laser can be very effective in reducing the risk of severe bleeding and progression in proliferative disease. However, it may not restore vision that has already been lost, and it can have side effects such as reduced peripheral or night vision, depending on the amount and location of treatment. The decision to use laser is therefore made carefully, balancing protection against advanced disease with preservation of visual function.

Vitrectomy Surgery for Advanced Disease

Vitrectomy is microsurgery performed inside the eye. It may be recommended when diabetic retinopathy causes persistent vitreous hemorrhage, tractional retinal detachment, dense scar tissue, or complications that threaten the macula. During vitrectomy, tiny instruments are introduced through small openings in the eye. The surgeon removes blood and the vitreous gel, relieves traction, treats scar tissue, and may apply laser treatment from inside the eye. In some cases, a gas bubble or silicone oil is placed to support the retina while it heals.

Vitrectomy is more complex than injections or office-based laser therapy and requires careful preoperative planning. Anesthesia may be local with sedation or general anesthesia, depending on the patient and surgical details. The duration varies according to the complexity of bleeding, scar tissue, and retinal detachment. Some surgeries are completed relatively quickly, while complex diabetic retinal detachments may take longer.

After surgery, patients receive eye drops and detailed instructions. If gas is used, head positioning may be necessary, and air travel may be restricted until the gas bubble has resolved. If silicone oil is used, a later procedure may be needed to remove it. Recovery depends on the severity of the retinal disease before surgery and whether the macula was affected. The surgeon will explain realistic expectations before the procedure.

Recovery and Follow-Up

Recovery from diabetic retinopathy treatment varies widely. After injections, many patients resume routine activities soon, though the eye may feel scratchy or look mildly red for a short time. After laser, vision may be temporarily blurred, and light sensitivity can occur. After vitrectomy, recovery is longer and more structured, with activity restrictions, eye drops, and scheduled postoperative visits.

Follow-up is essential because diabetic retinopathy is a chronic condition. Treatment can control active disease, but diabetes continues to influence the retina over time. Patients may need repeat imaging, additional injections, further laser, or monitoring for complications. A durable result often depends on both retinal treatment and steady management of blood sugar, blood pressure, cholesterol, kidney function, and smoking cessation when relevant.

Why Acting Early Matters

Diabetic retinopathy can progress before vision changes are noticeable. The retina may show hemorrhages, swelling, or poor circulation while the patient still reads well and functions normally. This silent progression is one reason regular eye screening is recommended for people with diabetes. Once central vision is affected or bleeding occurs, treatment may become more urgent and recovery less predictable.

Delaying care can allow diabetic macular edema to become chronic, which may damage retinal cells responsible for central vision. Proliferative diabetic retinopathy can lead to sudden vitreous hemorrhage, scar formation, or tractional retinal detachment. Severe disease may also contribute to neovascular glaucoma, a painful and difficult-to-treat condition caused by abnormal blood vessel growth in the front of the eye.

Early treatment does not mean every patient needs an immediate procedure. Sometimes the correct action is careful observation with improved systemic control and scheduled imaging. But early specialist evaluation helps determine which patients can be safely monitored and which need timely intervention. It also allows the physician to treat disease before complications narrow the available options.

Potential Benefits of Diabetic Retinopathy Treatment

The benefits of treatment depend on the stage of disease, the cause of vision loss, and how the retina responds, but the main aims are to preserve sight, reduce complications, and support long-term eye health.

Benefit	What It Means for You
Protection of remaining vision	Treatment can slow or stop active retinal damage, helping preserve the vision you still have.
Reduction of macular swelling	Injections and selected laser treatments may reduce fluid in the central retina, which can improve or stabilize reading and detailed vision.
Lower risk of major bleeding	Laser therapy and medications can help control fragile abnormal vessels that may bleed into the eye.
Treatment of advanced complications	Vitrectomy surgery can remove blood, relieve traction, and address retinal detachment in selected advanced cases.
Clearer long-term monitoring	Regular imaging creates a record of your retinal condition and helps guide future decisions with more precision.

Recovery Timeline After Treatment

Recovery is different for injections, laser therapy, and surgery, but the following overview describes what many patients can generally expect.

Time Period	What Patients Can Expect
Day 1	After injections or laser, mild irritation, redness, light sensitivity, or blurred vision may occur. After surgery, the eye is usually protected, and drops are started as instructed.
First Week	Patients attend follow-up as advised. Vision may fluctuate. After vitrectomy, activity restrictions, positioning, and careful use of eye drops are especially important.
First Month	Retinal swelling or bleeding may begin to improve, although some patients need additional treatment. Surgical patients usually have ongoing monitoring of healing and retinal position.
Longer Term	Diabetic retinopathy requires continued surveillance. Repeat injections, additional laser, or further intervention may be needed depending on disease activity and systemic diabetes control.

Factors That Influence Outcomes

Outcomes in diabetic retinopathy are influenced by both eye-related and whole-body factors. The earlier active disease is detected, the more opportunity there is to protect retinal tissue before permanent damage occurs. Patients with recent-onset macular edema may respond differently than those with long-standing swelling and structural retinal changes. Similarly, surgery performed before severe macular damage may have a different outlook than surgery performed after prolonged traction or detachment.

Important factors include the stage of retinopathy, whether the macula is involved, the presence of ischemia or poor retinal blood flow, prior treatments, cataract or glaucoma, and the condition of the other eye. The clarity of the eye’s media also matters; dense cataract or vitreous hemorrhage can make diagnosis and laser treatment more difficult, sometimes requiring surgery or combined planning.

Systemic health is equally important. Long-term blood sugar control, blood pressure management, cholesterol levels, kidney disease, anemia, pregnancy, and smoking can all affect progression. Rapid changes in blood sugar control may also influence retinopathy in some patients, which is why coordination with diabetes specialists is valuable. For patients using insulin pumps, multiple medications, anticoagulants, or treatment for kidney disease, the retina specialist may collaborate with other physicians to reduce procedural risk and support ongoing care.

Adherence to follow-up is another major factor. Intravitreal medications often work best when given on an appropriate schedule and adjusted according to imaging. Missing visits can allow swelling or abnormal vessels to return. After vitrectomy, following postoperative instructions—including drops, positioning, and travel restrictions when gas is used—can be important for healing.

A good result is not measured only by a vision chart. For many patients, success means stabilizing vision, preventing severe complications, reducing the burden of bleeding or swelling, and maintaining independence in daily activities. The treating physician should discuss realistic goals based on the specific findings in each eye.

Why International Patients Choose Acibadem for Diabetic Retinopathy Care

International patients considering care abroad often want more than a procedure. They need an accurate diagnosis, a careful explanation of options, coordinated scheduling, language support, and a treatment plan that can continue after they return home. Diabetic retinopathy care is especially dependent on this structure because it may involve repeated visits, imaging comparisons, systemic medical coordination, and long-term follow-up.

Acibadem hospitals provide diabetic retinopathy evaluation and treatment within JCI-accredited hospital environments, supported by experienced ophthalmologists and retina specialists. Care is guided by international and evidence-based protocols, with diagnostic pathways designed to identify the exact mechanism of vision threat: macular swelling, abnormal vessel growth, retinal ischemia, bleeding, traction, or detachment. This helps avoid both undertreatment and unnecessary intervention.

For patients with complex diabetes or multiple medical conditions, multidisciplinary coordination can be important. Retina specialists may work with endocrinology, internal medicine, cardiology, nephrology, anesthesiology, and other departments when needed. In more complex cases, specialist boards or multidisciplinary discussions can support treatment planning, particularly when surgery, systemic disease optimization, or combined eye conditions are involved.

Advanced ophthalmic imaging and microsurgical capabilities allow physicians to assess the retina in detail and choose the appropriate treatment approach. Imaging technologies help measure macular fluid, document retinal circulation, detect peripheral disease, and monitor response over time. In surgical cases, modern visualization systems, fine intraocular instruments, and retinal laser techniques help the surgeon work with precision inside delicate eye structures. The value of technology lies not in the equipment itself, but in how it supports safer planning, accurate treatment, and careful follow-up.

Acibadem International supports patients traveling from abroad with services in more than 20 languages. Depending on the patient’s needs, support may include appointment planning, medical record coordination, interpreter assistance, hospital admission guidance, and help with travel-related logistics. For diabetic retinopathy, this can be particularly helpful because the timing of imaging, injections, laser, surgery, and postoperative checks must be organized thoughtfully.

Personalized treatment planning is central. A patient who needs a second opinion after years of injections will have different needs from someone with a new diagnosis of diabetic macular edema. A patient with sudden vitreous hemorrhage may require a different pathway than a patient with mild retinopathy found during screening. International care should respect the patient’s medical priorities, travel schedule, follow-up possibilities, and long-term relationship with physicians at home.

Taking the Next Step

Diabetic retinopathy is a serious condition, but it is also one of the eye diseases where timely diagnosis and well-planned treatment can make a meaningful difference. If you have diabetes and have noticed vision changes, have been told you have retinal swelling or bleeding, or want a second opinion about injections, laser therapy, or surgery, a retinal specialist evaluation can clarify your options.

At Acibadem, diabetic retinopathy care is designed to combine detailed retinal imaging, experienced specialist assessment, coordinated medical support, and a clear plan for treatment and follow-up. For international patients, the process can begin with sharing medical records and recent eye images, followed by guidance on the most appropriate consultation or treatment pathway.

If you are concerned about your vision, do not wait for symptoms to become severe. Requesting a consultation or second opinion can help you understand the stage of disease, whether treatment is needed now, and how to protect your sight over the long term.

This information is general and is not a substitute for professional medical advice. Diagnosis and treatment decisions should be made after consultation with a qualified physician who can assess your individual condition.